ARCHIVES

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

DCBDC To Contract For CA Agents In Vaccine Testing

November 15, 1991

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

Funding opportunities listed.

March 26, 2004

NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients

November 11, 2011

DCT Counselors Ponder Coordination, New Opportunities

December 12, 1975

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001